https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Colorectal cancer metastatic disease progression in Australia: a population-based analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34273 79 years vs < 60 years: 1.38 for colon, 1.69 for rectal cancer). Risk of disease progression was significantly lower for females, and varied by histology type. For colon cancer, the risk of disease progression decreased over time. For rectal cancer, risk of metastatic progression was significantly higher for those living in more socioeconomically disadvantaged areas compared with those in the least disadvantaged area. Conclusions: An understanding of the variation in risk of metastatic progression is useful for planning health service requirements, and can help inform decisions about treatment and follow-up for colorectal cancer patients.]]> Wed 17 Nov 2021 16:32:24 AEDT ]]> Conditional survival of cancer patients: an Australian perspective https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21190 Wed 11 Apr 2018 15:05:38 AEST ]]> Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time - An Australian population-based record linkage study, 2001-2016 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54299 Thu 15 Feb 2024 14:53:02 AEDT ]]> Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14026 Sat 24 Mar 2018 10:38:31 AEDT ]]> Psychometric properties of cancer survivors' unmet needs survey https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12252 Sat 24 Mar 2018 08:08:09 AEDT ]]> A population-based study of progression to metastatic prostate cancer in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21004 74 years: HR=2.73, 95% CI: 2.55-2.93), and those living in inner regional (HR=1.11, 95% CI: 1.04-1.18) or rural areas (HR=1.24, 95% CI: 1.14-1.36) or more disadvantaged areas (middle tertile: HR=1.09, 95% CI: 1.02-1.16; most disadvantaged: HR=1.12, 95% CI: 1.04-1.19). The risk of developing metastatic disease decreased over calendar time (adjusted HR=0.98, 95% CI: 0.97-0.99 per year). Conclusions: After a median follow-up of 6.8 years more than 1 in 5 men diagnosed with non-metastatic prostate cancer developed distant metastases. This estimate of the overall risk of developing metastatic disease in the population, and the geographical disparities identified, can inform the planning of required cancer services.]]> Sat 24 Mar 2018 07:50:38 AEDT ]]> Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23724 Sat 24 Mar 2018 07:16:57 AEDT ]]>